Ontology highlight
ABSTRACT: Background
Elevated levels of endothelial cell (EC)-derived extracellular vesicles (EVs) circulate in patients with antiphospholipid antibodies (APLAs), and APLAs, particularly those against β2 -glycoprotein I (β2 GPI), stimulate EV release from ECs. However, the effects of EC-derived EVs have not been characterized.Objective
To determine the mechanism by which EVs released from ECs by anti-β2 GPI antibodies activate unstimulated ECs.Patients/methods
We used interleukin (IL)-1 receptor inhibitors, small interfering RNA (siRNA) against Toll-like receptors (TLRs) and microRNA (miRNA) profiling to assess the mechanism(s) by which EVs released from ECs exposed to anti-β2 GPI antibodies activated unstimulated ECs.Results and conclusions
Anti-β2 GPI antibodies cau
SUBMITTER: Wu M
PROVIDER: S-EPMC4877623 | biostudies-literature | 2015 Oct
REPOSITORIES: biostudies-literature